ImmunoGen Aktie

Kaufen
Verkaufen
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Bei einem anderen Broker handeln Smartphone
Div. Rendite 0,00%

WKN 878613

ISIN US45253H1014

Symbol IMGN


ImmunoGen Aktie Analyse

13.08.19 ImmunoGen Buy H.C. Wainwright & Co.
06.05.19 ImmunoGen Buy H.C. Wainwright & Co.
06.05.19 ImmunoGen Outperform Cowen and Company, LLC
08.02.18 ImmunoGen Outperform RBC Capital Markets
31.01.18 ImmunoGen Buy H.C. Wainwright & Co.
06.07.17 ImmunoGen Outperform RBC Capital Markets
29.07.15 ImmunoGen Outperform Oppenheimer & Co. Inc.
27.07.15 ImmunoGen Outperform RBC Capital Markets
01.06.15 ImmunoGen Buy Canaccord Adams
27.04.15 ImmunoGen Buy Canaccord Adams
06.02.15 ImmunoGen Outperform Oppenheimer & Co. Inc.
22.12.14 ImmunoGen Outperform RBC Capital Markets
30.10.12 ImmunoGen buy Jefferies & Company Inc.
27.08.12 ImmunoGen outperform RBC Capital Markets
06.08.12 ImmunoGen buy Jefferies & Company Inc.
04.06.12 ImmunoGen outperform RBC Capital Markets
08.12.11 ImmunoGen outperform RBC Capital Markets
27.09.11 ImmunoGen outperform RBC Capital Markets
08.04.11 ImmunoGen outperform RBC Capital Markets
19.11.09 ImmunoGen buy Brean Murray, Carret & Co., LLC
30.10.09 ImmunoGen buy Brean Murray, Carret & Co., LLC
08.10.09 ImmunoGen buy Brean Murray, Carret & Co., LLC
08.10.09 ImmunoGen buy Brean Murray, Carret & Co., LLC
07.07.09 ImmunoGen outperform Oppenheimer & Co. Inc.
20.05.08 ImmunoGen Global Biotech Investing
20.03.08 ImmunoGen spekulativ kaufen Der Aktionär
16.10.07 ImmunoGen outperform RBC Capital Markets
05.10.07 ImmunoGen buy Ferris Baker Watts
22.11.06 ImmunoGen Buy Cantor Fitzgerald
15.08.05 ImmunoGen outperform RBC Capital Markets